Phase II study of a weekly liposomal paclitaxel formulation (Genexol®-PM) and gemcitabine® combination chemotherapy in patients with advanced biliary cancer.

被引：0
|
作者：
Uk, Keon Kean Uk [1 ]
Kim, Jin Young [1 ]
Do, Young Rok [1 ]
Song, Hong Suk [1 ]
Jeon, Young June [1 ]
Ryoo, Hun Mo [2 ]
Bae, Sung Hwa [2 ]
Kim, Jong Gwang [3 ]
Baek, Jin Ho [4 ]
Chae, Yee Soo [3 ]
Kim, Min Kyoung [5 ]
Lee, Kyung Hee [5 ]
Cho, Yoon Young [6 ]
机构：
[1] Keimyung Univ, Dongsan Med Ctr, Taegu, South Korea
[2] Daegu Catholic Univ Hosp, Taegu, South Korea
[3] Kyungpook Natl Univ Hosp, Taegu, South Korea
[4] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Ulsan 680749, South Korea
[5] Yeungnam Univ Hosp, Taegu, South Korea
[6] Dongguk Univ, Med Ctr, Gyeongju, South Korea
来源：
CANCER RESEARCH | 2013年 / 73卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2013-4659
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4659
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase I pharmacokinetic study of a weekly liposomal paclitaxel formulation (Genexol®-PM) in patients with solid tumors
    Lim, W. T.
    Tan, E. H.
    Toh, C. K.
    Hee, S. W.
    Leong, S. S.
    Ang, P. C. S.
    Wong, N. S.
    Chowbay, B.
    ANNALS OF ONCOLOGY, 2010, 21 (02) : 382 - 388
  • [2] A Phase II study of weekly nab-paclitaxel in combination with gemcitabine in patients with metastatic breast cancer.
    Zhao, Yannan
    Lv, Fangfang
    Chen, Shen
    Lu, Yunhua
    Cao, Enying
    Wang, Zhonghua
    Zhang, Jian
    Zhang, Sheng
    Cao, Jun
    Zheng, Chunlei
    Wang, Leiping
    Wang, Biyun
    Hu, Xichun
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [3] A PHASE II TRIAL OF GENEXOL-PM(A CREMOPHOR-FREE, POLYMERIC MICELLE FORMULATION OF PACLITAXEL) AND GEMCITABINE IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER.
    Cho, Eun Kyung
    Kang, Shin Myung
    Jung, Minkyu
    Ahn, Hee Kyung
    Park, Inkeun
    Kim, Young Saing
    Hong, Junshik
    Sym, Sun Jin
    Park, Jinny
    Shin, Dong Bok
    Lee, Jae Hoon
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S574 - S575
  • [4] A phase II trial of cationic liposomal paclitaxel in combination with gemcitabine in patients with advanced pancreatic cancer
    Loehr, J. M.
    Bodoky, G.
    Foelsch, U.
    Maerten, A.
    Lilla, C.
    Meyer, I.
    Osinsky, D.
    Szanto, J.
    Lutz, M.
    EJC SUPPLEMENTS, 2009, 7 (02): : 386 - 386
  • [5] Cationic liposomal paclitaxel in combination with gemcitabine in patients with advanced pancreatic cancer: A phase II trial
    Loehr, M.
    Bodoky, G.
    Folsch, U.
    Marten, A.
    Karrasch, M.
    Lilla, C.
    Meyer, I.
    Osinsky, D.
    Szanto, J.
    Lutz, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [6] Multicenter Phase II Clinical Trial of Genexol-PM® with Gemcitabine in Advanced Biliary Tract Cancer
    Kim, Jin Young
    Do, Young Rok
    Song, Hong Suk
    Cho, Yoon Young
    Ryoo, Hun Mo
    Bae, Sung Hwa
    Kim, Jong Gwang
    Chae, Yee Soo
    Kang, Byung Woog
    Baek, Jin Ho
    Kim, Min Kyoung
    Lee, Kyung Hee
    Park, Keonuk
    ANTICANCER RESEARCH, 2017, 37 (03) : 1467 - 1473
  • [7] A phase II study of weekly paclitaxel and doxifluridine (an intermediate metabolite of capecitabine) combination chemotherapy for advanced/recurrent gastric cancer.
    Takeyoshi, I
    Makita, F
    Tanahashi, Y
    Iwazaki, S
    Nakamura, S
    Ogawa, T
    Ishikawa, H
    Ohya, T
    Kawate, S
    Morishita, Y
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 328S - 328S
  • [8] A Phase II Study of Weekly Paclitaxel and Doxifluridine Combination Chemotherapy for Advanced/Recurrent Gastric Cancer
    Takeyoshi, Izumi
    Makita, Fuji
    Tanahashi, Yoshifumi
    Iwazaki, Shigeru
    Ogawa, Tetsushi
    Tomizawa, Naoki
    Nakamura, Seiji
    Ishikawa, Hitoshi
    Ohya, Toshihiro
    Kakinuma, Shinichi
    Nakagami, Katsunao
    Sato, Yoshihiro
    Koyano, Tetsuya
    Roppongi, Takashi
    Izumi, Masaru
    Kobayashi, Junya
    Kawate, Susumu
    Sunose, Yutaka
    Kobayashi, Mitsunobu
    Yamada, Tatsuya
    Sakamoto, Ichiro
    ANTICANCER RESEARCH, 2011, 31 (01) : 287 - 291
  • [9] Multicenter phase II study of weekly paclitaxel plus cisplatin combination chemotherapy in patients with advanced gastric cancer
    Jong Gwang Kim
    Sang Kyun Sohn
    Hong Suk Song
    Ki-Young Kwon
    Young Rok Do
    Kyung Hee Lee
    Myung Soo Hyun
    Hun Mo Ryoo
    Sung Hwa Bae
    Keon Uk Park
    Jin Ho Baek
    Won Sik Lee
    Joo Seop Chung
    Goon Jae Cho
    Chang-Hak Sohn
    Jung Soon Jang
    Ho Young Chung
    Wansik Yu
    Cancer Chemotherapy and Pharmacology, 2007, 60
  • [10] Multicenter phase II study of weekly paclitaxel plus cisplatin combination chemotherapy in patients with advanced gastric cancer
    Kim, Jong Gwang
    Sohn, Sang Kyun
    Song, Hong Suk
    Kwon, Ki-Young
    Do, Young Rok
    Lee, Kyung Hee
    Hyun, Myung Soo
    Ryoo, Hun Mo
    Bae, Sung Hwa
    Park, Keon Uk
    Baek, Jin Ho
    Lee, Won Sik
    Chung, Joo Seop
    Cho, Goon Jae
    Sohn, Chang-Hak
    Jang, Jung Soon
    Chung, Ho Young
    Yu, Wansik
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (06) : 863 - 869
12345